Consistent with our findings, Drover and colleagues have shown that CD36 deficiency impairs intestinal lipid processing, leading to secretion defect and then hypertriglyceridemia [23], and another group led by Ibrahimi discovered that overexpressing CD36 could reduce plasma TG [24]. The gene discussed is CD36; the disease is hypertriglyceridemia.